Broncodilation for the treatment of respiratory disease where bronchospasm
occurs and increased mucaciliary is expectoration is required.
Special
Features
Sympathomimetic amine. Blocks beta-2 receptor sites in the body, which includes
the lungs and uterus. Concentrating activity to these sites maximizes the
beneficial effects of pulmonary ventilation and mucociliary while having minimal
effect on the cardiovascular system.
Dosage and
Administration
Horses 2.5 gm/ 50kg bodyweight twice daily for 10 days.
In chronic respiratory
conditions the dose may be halved and extended for 20 days.
